Integra Lifesciences Holdings Corp
IART- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000917520
No open-market purchases or sales by Integra Lifesciences Holdings Corp insiders were filed in the last 90 days; 212 institutions reported holding it in 13F filings for Q2 2026, worth $1.32B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Integra Lifesciences Holdings Corp as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 284
- +25 vs. Q3 2023
- Shares held
- 66.9M
- −1.65M (−2.4%) vs. Q3 2023
- Total value
- $2.92B
- +$289.4M (+11.0%) vs. Q3 2023
- New holders
- 50
- 86 more added
- Sold out
- 25
- 106 more reduced
4 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IART on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 212 | $1.32B |
| Q1 2026 | 202 | $704.7M |
| Q4 2025 | 205 | $919.4M |
| Q3 2025 | 207 | $1.04B |
| Q2 2025 | 209 | $896.9M |
| Q1 2025 | 220 | $1.62B |
| Q4 2024 | 223 | $1.57B |
| Q3 2024 | 225 | $1.24B |
| Q2 2024 | 238 | $2.07B |
| Q1 2024 | 281 | $2.34B |
| Q4 2023 | 284 | $2.92B |
| Q3 2023 | 263 | $2.63B |
| Q2 2023 | 283 | $2.85B |
| Q1 2023 | 280 | $4.18B |
| Q4 2022 | 281 | $4.20B |
| Q3 2022 | 282 | $3.13B |
| Q2 2022 | 285 | $3.95B |
| Q1 2022 | 278 | $4.80B |
| Q4 2021 | 277 | $5.19B |
| Q3 2021 | 262 | $5.27B |
| Q2 2021 | 264 | $5.10B |
| Q1 2021 | 257 | $5.10B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Integra Lifesciences Holdings Corp; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Park Place Capital Corp | 0 | $0 | 0.00% | −311−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −105−100.0% | Sold out |
| GoalVest Advisory LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Front Row Advisors LLC | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Baker Avenue Asset Management, LP | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Washington Trust Co | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Tfo-TDC, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| Advisor Partners II, LLC | – | – | – | – | Not filed |
| KB Financial Partners, LLC | – | – | – | – | Not filed |
| Steward Financial Group LLC | – | – | – | – | Not filed |